iThera Medical

iThera Medical develops and markets advanced optoacoustic imaging systems that enable real-time visualization of anatomical, functional, and molecular information deep within living tissue. Their flagship technology MSOT has been validated in preclinical research globally and translated to early clinical studies for non-invasive assessment of conditions like peripheral arterial disease. The company’s platforms are used to study disease mechanisms at the molecular level and analyze pharmacokinetics/biodistribution of new substances. Recent clinical results highlight MSOT’s value for monitoring microvascular perfusion post-revascularization procedures.